• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Zika virus - Articles and news items

zika virus

FDA approves Abbott’s molecular Zika virus test

Industry news / 3 February 2017 / Niamh Marriott, Digital Editor

The US Food and Drug Administration (FDA) has authorised Abbott’s molecular test to detect Zika virus in whole blood (when collected alongside a patient-matched serum or plasma sample) for emergency use. This is the first molecular test made by a commercial manufacturer authorised to detect Zika in whole blood samples; this is significant since the […]

BARDA grants Sanofi $43.2 million for Zika vaccine development

Industry news / 27 September 2016 / Niamh Louise Marriott, Digital Content Producer

In July, Sanofi revealed the development agreement with the Walter Reed Army Institute of Research on the co-development of a Zika vaccine candidate…

Approval for first-in-human Zika vaccine trial to go ahead

Industry news / 20 June 2016 / Victoria White, Digital Content Producer

Inovio and GeneOne Life Science have received approval to initiate a Phase I human trial to evaluate Inovio’s Zika DNA vaccine (GLS-5700)…

Allergan and Medicines360 donate IUDs in response to Puerto Rico Zika outbreak

Industry news / 1 June 2016 / Victoria White, Digital Content Producer

Allergan and Medicines360 are to donate 10,000 units of Liletta to the CDC Foundation in response to the Zika virus outbreak in Puerto Rico…

Maternal immunisation

Blog / 3 March 2016 / Emmanuel Hanon, Senior Vice President, Head of Vaccines Research & Development, GSK

Here, GSK’s Emmanuel Hanon discusses maternal vaccination and how it has emerged as a promising public health strategy…

Wanted: Zika virus researchers

Blog / 10 February 2016 / Victoria White, European Pharmaceutical Review

The MRC has launched a £1m rapid response funding initiative to better understand the nature of the risk posed by the Zika virus. Find out about this initiative and NIH’s call for research here…

Zika Virus: a public emergency of international concern

Blog / 4 February 2016 / Victoria White, European Pharmaceutical Review

The Zika virus has taken hold in South America. Its possible link to microcephaly in newborn babies and neurological conditions has led the World Health Organization to declare a Public Health Emergency of International Concern. Here we discuss the virus, countermeasures and the race for a vaccine…